London, 30 October 2025: The UK Government has announced a landmark £55 billion R&D funding allocation to strengthen the nation’s position as a global leader in science, technology, and innovation. The investment, confirmed by the Department for Science, Innovation and Technology (DSIT), represents the largest-ever long-term commitment
London, 24 Oct 2025: A patient with multiple sclerosis (MS) in the UK has become the first to receive CAR T cell therapy, an innovative treatment developed by researchers at University College London (UCL), as part of a clinical trial investigating whether this personalised approach can slow or even stop
The landscape of modern healthcare is undergoing a revolutionary transformation, driven by cell and gene therapy innovations shaping 2025. These cutting-edge innovations are redefining what’s possible in medicine, offering hope to patients with diseases once thought incurable. From cancer treatment to genetic disorder correction, advanced therapies are reshaping the
Healthcare is undergoing a profound transformation, one that’s being shaped by the convergence of two of the most powerful technological forces of our time: Biotechnology and Artificial Intelligence (AI). On their own, each field has sparked scientific revolutions. But together, they are fundamentally redefining how we understand, prevent, diagnose,
United Kingdom, October 6, 2025: AstraZeneca has entered into a licensing agreement worth up to $555 million with Algen Biotechnologies, a U.S.-based biotech firm that leverages artificial intelligence for gene-editing discoveries. Under the deal, AstraZeneca will gain exclusive rights to develop and commercialize therapies discovered through Algen’s